Storia in 2 fonti

MassBio CEO calls 2025 ‘probably the most challenging year that I can remember’

MassBio report shows MA biopharma jobs fell 3.1%, NIH awards dropped 6%, while China's drug pipeline grew 36% in 2025, alarming CEO Kendalle Burlin O'Connell.

Raccontata da

statnews.com

endpoints.news

Confronto fonti

2 prospettive sulla stessa storia

AI · summaries

endpoints.newsStai leggendo11 g fa

MassBio CEO calls 2025 ‘probably the most challenging year that I can remember’

MassBio report shows MA biopharma jobs fell 3.1%, NIH awards dropped 6%, while China's drug pipeline grew 36% in 2025, alarming CEO Kendalle Burlin O'Connell.

originale

statnews.com12 g fa

After a years-long slump, Massachusetts biopharma sector has come roaring back in 2026

The number of people working in Massachusetts’ biotech sector fell last year, for the first time since at least 2002. But 2026 is looking up.

Leggi questa versione → originale

Timeline cronologica

martedì 25 agosto 2026·statnews.com
After a years-long slump, Massachusetts biopharma sector has come roaring back in 2026
The number of people working in Massachusetts’ biotech sector fell last year, for the first time since at least 2002. But 2026 is looking up.
mercoledì 26 agosto 2026·endpoints.news
MassBio CEO calls 2025 ‘probably the most challenging year that I can remember’
MassBio report shows MA biopharma jobs fell 3.1%, NIH awards dropped 6%, while China's drug pipeline grew 36% in 2025, alarming CEO Kendalle Burlin O'Connell.